Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. - Wikidata - wikimedia - TriplyDB

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

http://www.wikidata.org/entity/Q35209967

about

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications More breast cancer genes?Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer Common fragile sites are preferential targets for HPV16 integrations in cervical tumors Role of the modulation of CYP1A1 expression and activity in chemoprevention A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.Classifying the Progression of Ductal Carcinoma from Single-Cell Sampled Data via Integer Linear Programming: A Case Study.Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.Defining a common region of deletion at 13q21 in human cancers.Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.Commonalities in Development of Pure Breeds and Population Isolates Revealed in the Genome of the Sardinian Fonni's Dog Molecular classification of familial non-BRCA1/BRCA2 breast cancer Inferring tree causal models of cancer progression with probability raising.Breast cancer susceptibility and the DNA damage response.ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer Decreased expression of LMO7 and its clinicopathological significance in human lung adenocarcinoma.Mutation analysis of the CHK2 gene in families with hereditary breast cancer.Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer A genome wide linkage search for breast cancer susceptibility genes.Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.Construction and analysis of tree models for chromosomal classification of diffuse large B-cell lymphomas.Tumour-suppression function of KLF12 through regulation of anoikis.Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.Construction of tree models for pathogenesis of nasopharyngeal carcinoma.High-density mapping and follow-up studies on chromosomal regions 1, 3, 6, 12, 13 and 17 in 28 families with chronic lymphocytic leukaemia.Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy Genome-wide scanning for linkage in Finnish breast cancer families No germline FH mutations in familial breast cancer patients

P2860

Q24535695-9C999B61-8140-4352-B6DA-1628E9A7C220 Q24597370-17108FA1-98EB-4CB2-8935-283F33DD91C7 Q24800072-E09CC27E-1F20-444A-8574-2DADB8BA725B Q24801368-BE4CC9F7-8737-4046-B518-69B93B86254D Q24802534-D9AC2447-AD8C-4CFD-93E9-5686A7B171D5 Q27022848-F4B671FC-E6A7-42B6-A2F4-C6154AB2F497 Q27309935-49ACADCA-49C7-4A43-8C82-71A0605176C3 Q28202820-DF560AD2-6739-4782-A9B4-2170647A96CE Q28212477-EBF1EA20-EF86-4251-B14F-91A92E49545B Q28307748-9E6B111A-7B67-4E49-BA61-46F15571F31F Q28384206-016A44BB-3856-430C-A5F5-807B45262B10 Q30476046-011A29D2-8A84-4A7B-BEB2-3F60D4A85C02 Q30992438-1BEAC9BC-013C-4E5A-AE82-5EDF789D151A Q33894527-2CD27378-91FB-4EC0-AB90-06AECA2C9923 Q33919065-38E357EB-81AB-4CC0-A2CD-730EB009A5B9 Q34082687-F4E88212-9BF6-4121-9489-863E0E1EFFE6 Q34173446-1F98BB38-B919-479F-B1C3-BD025D13752B Q34367165-D71D27E6-B764-4A1C-B0E9-154C097EC081 Q34537225-B0313043-0C09-408A-BA0F-93375BAF72C2 Q34807023-3F765DDB-2999-43E7-A732-ED84137051BD Q35316887-BC8B26DF-534D-4A83-929E-36EB9951FE5E Q36108626-41F50AA3-F76F-4006-813F-E07BF442B085 Q36113106-80ADC42A-464F-491C-8806-076ABB1588A1 Q36230875-C1F9FDBC-5F04-49CA-A195-0A789C60E237 Q36623420-0B484E4B-B21A-4ADE-B76B-232451633FB0 Q36670312-00DC928B-4389-45D7-AFB3-8EF2D6DAE579 Q36859142-A1995EC9-5C19-4370-BADC-02CD2AC4DAF4 Q37272982-96EFEBB1-CCB3-468D-89C2-C298DAED164E Q38492869-C2F88498-45EE-406C-91D9-91C35A3E2B83 Q39347119-80A0F690-FBBF-427F-8D73-65EF79CC1FD4 Q41974323-F466B879-772E-450F-8272-80CCB7B1D920 Q42461336-FAD27088-73CB-4014-9A94-2A17E8AF1F5E Q42519156-59E7A8FB-B6A5-4E1F-839F-88EDE4C50353 Q53270833-140145A2-8FBD-4B89-9F7D-8152FF14A351 Q53367696-CC5E940F-A23B-4489-93F5-C103B6214616 Q53634298-54AE61F0-46B7-4466-8EE4-760A458F3FE7 Q54415246-2654E5B2-659E-45A9-BDD4-AECC950FF157 Q57266788-59E34B92-3E8D-41F3-84DF-25271E09AF77 Q57274804-78EFBD0A-30A3-4DA1-BCE9-CE763E680115 Q57306224-2ACA2F29-4F28-4971-B1DD-A28ACC0EFE72

P2860

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

http://www.wikidata.org/entity/Q35209967

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@ast

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@en

type

label

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@ast

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@en

prefLabel

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@ast

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@en

P1433

Q35209967-094E4AFD-9C93-4101-AFDB-FBD2E98E5D88

P1476

Q35209967-66EB64A1-54DA-45C1-8895-81B49A6CB87F

P2093

Q35209967-07316B77-4EA9-4A6A-A117-76567D6B1D55

Q35209967-084F0C50-76F6-474F-A622-88870168DEB0

Q35209967-0A6C8D76-060C-4882-A8EF-48992119A0E6

Q35209967-19BDC155-7239-45A3-BDCA-4F4B045A2919

Q35209967-1CF89902-8A28-4C0D-8DB5-C5C156D1ACDB

Q35209967-28B15A72-EA5D-44C2-841E-C1AD57B791C1

Q35209967-2BDCD0AE-0B71-4FCF-8039-8C2C83BDA922

Q35209967-2E1F1AF2-D1C7-4640-8712-2904C0C6E3FC

Q35209967-34D194FF-F80A-479B-AF52-4057B47B309F

Q35209967-35782627-804A-4E05-9470-6D727B847380

P2860

Q35209967-092F58B9-5D21-4EF5-A03D-0DE0BD67569E

Q35209967-143BB95A-CF29-4E92-9F78-BE05021DD88D

Q35209967-30034CD7-FDCE-4F9C-ABBF-9C97EEB99307

Q35209967-35767158-5AA3-4392-B690-B9E3088F6D2A

Q35209967-3A51735C-B1DE-4D5E-8863-C45F02ECD7BA

Q35209967-3AA51D0C-D24E-4477-8239-457873CBD2FD

Q35209967-470C354F-0BB3-4944-B98D-27C724F5A1F5

Q35209967-4864EC18-2D00-4FBE-80CB-6B551D83041D

Q35209967-5A314D6E-450F-4629-8B7D-C5C583DF4BD0

Q35209967-6E9EBA07-0EF5-4FA0-B651-F3A9CC385117

P304

Q35209967-5CF77154-509E-4216-88D0-E2A4A7704B24

P31

Q35209967-6AC76FB1-C10C-4939-95FE-11043FADD4F4

P356

Q35209967-26FBF8BC-F3BE-4C33-85CE-5F2818E14B5B

P407

Q35209967-51744CAE-5251-4A17-A3DA-8AA54A7553AD

P433

Q35209967-F8291DED-BD80-4F07-968F-1CC39F150FDE

P478

Q35209967-388B56F9-3F89-4AFD-A8E8-B9FFDB1B2812

P50

Q35209967-2544E7D5-ADC4-4C03-9B23-CC8AA9B7ED84

Q35209967-55E93482-F199-4A69-AC15-A091D78429FC

Q35209967-838A47A0-7B73-4BAA-9AF3-C0A403FC0339

Q35209967-8EBCD27D-F02A-4EF5-9475-E44CE3D0832F

Q35209967-C93CFB25-5D06-4D12-A52B-19C260EC6665

P577

Q35209967-A43BA8A6-B6C4-4B7D-9C6A-7B5B94BAB24A

P5875

Q35209967-487028A4-61FC-462E-82C8-5E6D3EC3138C

P698

Q35209967-599B5C59-63B2-4C0A-9613-12B9B9063FA7

P921

Q35209967-54E99B43-DABF-4CA9-AEA0-D77BDEFF4BA8

P932

Q35209967-ADE8B418-CD25-40D6-9418-39DC2BBFF092

P356

PNAS.97.17.9603

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Somatic deletions in hereditar ...... t cancer susceptibility locus.

@en

P2093

Arason A

http://www.w3.org/2001/XMLSchema#string

Bailey-Wilson J

http://www.w3.org/2001/XMLSchema#string

Barkardottir RB

http://www.w3.org/2001/XMLSchema#string

Bergthorsson JT

http://www.w3.org/2001/XMLSchema#string

Borg A

http://www.w3.org/2001/XMLSchema#string

Desper R

http://www.w3.org/2001/XMLSchema#string

Eerola H

http://www.w3.org/2001/XMLSchema#string

Egilsson V

http://www.w3.org/2001/XMLSchema#string

Freas-Lutz D

http://www.w3.org/2001/XMLSchema#string

Gillanders E

http://www.w3.org/2001/XMLSchema#string

P2860

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

PedCheck: a program for identification of genotype incompatibilities in linkage analysis

Mutation and cancer: statistical study of retinoblastoma

Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium

Strategies for multilocus linkage analysis in humans

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase

Parameters of the human genome

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis

P304

9603-9608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.97.17.9603

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Grönberg

Heli Nevanlinna

Olli-Pekka Kallioniemi

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12377013

http://www.w3.org/2001/XMLSchema#string

P698

10944226

http://www.w3.org/2001/XMLSchema#string

P921

susceptibility locus

P932

16911

http://www.w3.org/2001/XMLSchema#string